Tissue engineering and 3D printing of bioartificial pancreas for regenerative medicine in diabetes

Trends Endocrinol Metab. 2021 Aug;32(8):609-622. doi: 10.1016/j.tem.2021.05.007. Epub 2021 Jun 18.

Abstract

Diabetes is a severe chronic disease worldwide. In various types of diabetes, the pancreatic beta cells fail to secrete sufficient insulin, at some point, to regulate blood glucose levels. Therefore, the replacement of dysfunctional pancreas, islets of Langerhans, or even the insulin-secreting beta cells facilitates physiological regulation of blood glucose levels. However, the current lack of sufficient donor human islets for cell replacement therapy precludes a routine and absolute cure for most of the existing diabetes cases globally. It is envisioned that tissue engineering of a bioartificial pancreas will revolutionize regenerative medicine and the treatment of diabetes. In this review, we discuss the anatomy and physiology of the pancreas, and identify the clinical considerations for engineering a bioartificial pancreas. Subsequently, we dissect the bioengineering problem based on the design of the device, the biomaterial used, and the cells involved. Last but not least, we highlight current tissue engineering challenges and explore potential directions for future work.

Keywords: (bioartificial) pancreas; 3D printing; beta cells; diabetes; tissue engineering; vascularization.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Blood Glucose
  • Diabetes Mellitus, Type 1* / therapy
  • Humans
  • Insulin
  • Pancreas / anatomy & histology
  • Pancreas / physiology
  • Pancreas, Artificial*
  • Printing, Three-Dimensional*
  • Regenerative Medicine
  • Tissue Engineering*

Substances

  • Blood Glucose
  • Insulin